Oaktree Acquisition Corp. III Life Sciences (OACC) stock
OACCNasdaqBlank ChecksFiscal year ends December 31Also trades as OACCU, OACCW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026
$10.70+0.00 (0.00%)
Close on Nov 13, 2026Market cap $263.04MP/E –Yield –
Oaktree Acquisition Corp. III Life Sciences ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?